{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Edison",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "68793",
      "recalling_firm": "Daiichi Sankyo Pharma Development",
      "address_1": "399 Thornall St",
      "address_2": "",
      "postal_code": "08837-2236",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1501-2014",
      "product_description": "Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc. Parsippany, NJ 07054  NDC 65597-113-30",
      "product_quantity": "5 bottles",
      "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping",
      "recall_initiation_date": "20140712",
      "center_classification_date": "20140731",
      "termination_date": "20150316",
      "report_date": "20140806",
      "code_info": "Lot #213655B Exp - 12/31/2017",
      "more_code_info": ""
    }
  ]
}